About the Virtual Global Forum

Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines was held from 20 - 22 April 2021. Nearly 370 people from 36 countries participated in the Virtual Global Forum, which provided an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convened researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.

INTERNATIONAL CONVENING OF THE

ORGANIZED IN COLLABORATION WITH

SPONSORED BY

Funding for this conference was made possible [in part] by 1 R13 AI 157206 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.